Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness Analysis

Li H, He W, Lin H, Du A, Zhang X, Yang H, Qu S

Risk Management and Healthcare Policy 2024, 17:1387-1394

Published Date: 27 May 2024